Conclusions of the corneal transplant follow up study

被引:119
作者
Vail, A
Gore, SM
Bradley, BA
Easty, DL
Rogers, CA
Armitage, WJ
机构
[1] UNIV BRISTOL,SOUTHMEAD HLTH SERV,DEPT TRANSPLANT SCI,PROFESSORIAL UNIT,BRISTOL BS10 5NB,AVON,ENGLAND
[2] UNIV LEEDS,INST EPIDEMIOL & HLTH SERV,LEEDS,W YORKSHIRE,ENGLAND
[3] INST PUBL HLTH,MRC,BIOSTAT UNIT,CAMBRIDGE,ENGLAND
[4] UNIV BRISTOL,BRISTOL EYE HOSP,DEPT OPHTHALMOL,BRISTOL,AVON,ENGLAND
[5] UNITED KINGDOM TRANSPLANT SUPPORT SERV AUTHOR,BRISTOL,AVON,ENGLAND
关键词
D O I
10.1136/bjo.81.8.631
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim-On the basis of finalised data from the Corneal Transplant Follow up Study to identify and quantify factors influencing corneal graft outcome in terms of graft survival, rejection, visual acuity, and astigmatism. Methods-Multifactorial analysis of 2777 grafts registered by the UK Transplant Support Service from July 1987 to June 1991. Results-Several recipient factors influencing graft survival, rejection, and visual acuity were identified, but no donor factors. Of the operative factors amenable to change, mixed suturing was associated with reduced graft survival, and larger grafts with increased risk of rejection but better visual acuity when surviving. There was increased risk of rejection with poor matching at HLA class I antigens, but mismatched HLA-DR grafts suffered less rejection than those with zero HLA-DR mismatches. Recipient age below 10 years was associated with increased risk of both rejection and graft failure. However, whereas increasing age above 10 years was not associated with differential graft survival, it was significantly associated with decreasing risk of rejection. Conclusions-While confirming possible benefits of HLA-A and B matching, the expense and delay involved in awaiting matched HLA-DR tissue is unlikely to be justified. Other donor factors are unrelated to graft outcome following screening of tissue by eye banks. The highest rates of graft failure and rejection happen in the early postoperative period, and factors influencing visual outcome are also apparent at this stage.
引用
收藏
页码:631 / 636
页数:6
相关论文
共 18 条
[1]  
Armitage WJ, 1997, INVEST OPHTH VIS SCI, V38, P16
[2]  
BRADLEY BA, 1995, TRANSPLANT P, V27, P1392
[3]  
*COLL CORN TRANSPL, 1992, ARCH OPHTHALMOL-CHIC, V110, P1392
[4]   Expansion of cytotoxic CD8(+) CD28(-) T cells in healthy ageing people, including centenarians [J].
Fagnoni, FF ;
Vescovini, R ;
Mazzola, M ;
Bologna, G ;
Nigro, E ;
Lavagetto, G ;
Franceschi, C ;
Passeri, M ;
Sansoni, P .
IMMUNOLOGY, 1996, 88 (04) :501-507
[5]   THE IMMUNOLOGY OF EXCEPTIONAL INDIVIDUALS - THE LESSON OF CENTENARIANS [J].
FRANCESCHI, C ;
MONTI, D ;
SANSONI, P ;
COSSARIZZA, A .
IMMUNOLOGY TODAY, 1995, 16 (01) :12-16
[6]   Thymic involution with ageing: Obsolescence or good housekeeping? [J].
George, AJT ;
Ritter, MA .
IMMUNOLOGY TODAY, 1996, 17 (06) :267-272
[7]  
GORE SM, 1995, TRANSPLANTATION, V60, P1033
[8]   IMMUNOSENESCENCE - AGING OF THE IMMUNE-SYSTEM [J].
PAWELEC, G ;
ADIBZADEH, M ;
POHLA, H ;
SCHAUDT, K .
IMMUNOLOGY TODAY, 1995, 16 (09) :420-422
[9]   REDUCED GRAFT-REJECTION WITH GOOD HLA-A AND HLA-B MATCHING IN HIGH-RISK CORNEAL TRANSPLANTATION [J].
SANFILIPPO, F ;
MACQUEEN, JM ;
VAUGHN, WK ;
FOULKS, GN .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (01) :29-35
[10]  
SANSONI P, 1993, BLOOD, V82, P2767